, inhibition of p38 nous PGC-1; however, these cytokines stimulated the ability of PGC-1 to coactivate NRF-1 a further 4-fold MAPK greatly reduces the stimulatory effect of the cyto-kines on PGC-1 to nearly control levels. Consistent with site that is not phosphorylated in the wild-type protein.
Phospho-specific antibodies will be required to directly this, activation of p38 MAPK by its upstream activator MKK6E stimulates the coactivation effect of PGC-1 on address this possibility. Cytokines also induced the same phosphorylation and mobility shift. As expected, the NRF-1 system, and this activation was suppressed by SB 202190 ( Figure 1B Figure  3D ). These results indicate that p38 MAP kinase directly phosphorylates PGC-1 both in vitro and in cells at three 1A). These results clearly indicate that these cytokines stimulate the coactivation function of PGC-1 through amino acid residues. NRF-1 and further suggest that it is mediated by the p38 MAPK pathway.
Stabilization Figures 3C, 3D , and 4A, both MKK6E and the had a positive effect on PGC-1 itself, rather than on the combination of TNF␣ and IL-1␣ increased the amount PGC-1/NRF-1 unit, we performed similar studies using of PGC-1 protein. In addition, the triple mutant PGC-1 GAL4-DBD-PGC-1 in combination with a variety of cyto-3A resistant to phosphorylation had an elevated level kines. As shown in Figure 2A , many different cytokines of expression in the control treatment, and this level including TNF␣, IL-1␣, and IL-1␤ activated GAL4-DBDwas largely insensitive to further stimulation by MKK6E PGC-1 but not the GAL4-DBD alone. In data not shown, or cytokines. At first glance, it seems a bit paradoxical the GAL4-DBD fused to the PGC-1 activation domain that the triple mutant had elevated PGC-1 levels relative (1-170) was also not activated by cytokines. In all cases, to the wild-type protein; however, other examples, as the activation shown on GAL4-DBD-PGC-1 was blocked with p53, have been observed where phosphorylation by treatment of cells with the p38 inhibitor, SB 202190. events stabilize the protein, and mutation of these serConsistent with this, expression of MKK6E increased ine/threonine sites to alanine leads to increased protein GAL4-DBD-PGC-1 transcriptional activity, and this was levels (Shieh et al., 1997; Sakaguchi et al., 2000). Prelargely suppressed by the specific p38 MAPK inhibitor, sumably, these substitutions affect interactions with SB 202190 (Figure 2B ). That the p38 pathway, rather factors involved in protein turnover. than the JNK pathway, was functioning here was also Given that we observed that phosphorylation of indicated by the fact that an upstream activator of JNK PGC-1 by p38 MAPK was associated with an increase (MKK7) did not activate GAL4-DBD-PGC-1 (data not in the levels of this protein, we studied whether the shown).
effects Figure 3A) . In vitro phosphorylastabilization by either phosphorylation or triple mutation tion of recombinant-expressed PGC-1 by p38 MAPK are under investigation. followed by mass spectrometry indicated that these sites were indeed phosphorylated directly by p38 MAPK (data not shown). Furthermore, analysis of this in vitro Mutation of PGC-1 Phosphorylation Sites Abolishes Its Increased Transcriptional Activity by p38 MAPK phosphorylation with alanine substitution at these sites illustrates that the complete inhibition of phosphorylaTo directly determine the effects of phosphorylation on transcriptional activity of PGC-1, we performed transient tion required the mutation of all three residues (Figure 3B) . transfection analysis using the NRF-1 system with wildtype and mutant PGC-1 proteins. As shown in Figure  Phosphorylation Figure 3C ). Complete suppression of this phosphorylation and shift could be observed only abrogated by mutation of the three p38 MAPK phosphorylation sites of PGC-1. Importantly, these data also in the 262A/265A/298A triple mutant (PGC-1 3A) ( Figure  3C ). Of course, it is formally possible that mutation of show that the triple PGC-1 mutant, though stable, is not as transcriptionally active as the phosphorylated one site could facilitate the phosphorylation of another the triple PGC-1 mutant did not affect the uncoupling able to specifically induce UCP-3 in a PGC-1-dependent manner. In addition, the fact that the triple mutant of proteins UCP-2 and UCP-3. In all cases, the triple mutant was resistant to the stimulatory effects of the MKK6E PGC-1 has similar stability as the phosphorylated wildtype protein but does not activate some of the known ( Figure 6A) .
In order to investigate the effects of cytokines on PGC-1 targets (e.g., uncoupling proteins) indicates that these phosphorylations must regulate functions in addigene expression, similar experiments were performed treating PGC-1 expressing cell lines with cytokines. As tion to its stability. shown in Figure 6B like effects in vivo, we utilized transgenic mice that express PGC-1 from the muscle creatine kinase (MCK) indicating that these stimulatory effects were mediated by the p38 MAPK pathway. These data indicate that promoter. Several strains of mice were created; in these experiments we utilized a strain that has only a modest activation of the p38 MAP kinase pathway increases gene expression associated with mitochondrial respiraelevation in PGC-1 expression (2.3-fold) ( Figure 7A ). Importantly, this strain also has no alteration in respiration tion. In particular, activation of this signaling pathway is in the basal state (Ϫ2 hr, in Figure 7B ). To challenge To investigate whether this increased respiration was related to mitochondrial function, we isolated mitochonthese mice, we utilized a short-term model of cachexia, injection of lipopolysaccharide (LPS), an active compodria from control and transgenic mice at the 12 hr time point and analyzed respiration in vitro. Respiration was nent of bacterial endotoxin. This agent induces multiple cytokines and also brings about fever, hypermetabomeasured under conditions of ADP excess (state 3, coupled respiration) and ADP depletion (state 4, uncoupled lism, and anorectic responses characteristic of bacterial infection (Parillo, 1993). When these mice were injected respiration). As shown in Figure 7C , mitochondria from the transgenic mice showed similar respiration in the with 4 mg/kg of LPS, a relatively low dose, control animals showed little respiratory response. The transgenic basal state. However, LPS injection led to increased respiration, per unit of mitochondrial protein, in both the mice, however, showed a doubling of respiration at the 12 hr time point. Importantly, LPS injection caused no coupled and uncoupled states. mRNA analysis indicated that LPS injection caused a change in PGC-1 mRNA levels in control or the transgenic mice but did stimulate an increase in PGC-1 promodest increase in mRNAs for UCP-3, UCP-2, cytochrome-c, and COX-IV in control mice. However, these tein levels ( Figure 7A) ; the ability of LPS to alter PGC-1 protein levels without altering mRNA amount is consischanges were consistently greater in the transgenic mice. Notably, UCP-3 was induced 6-fold in the transgenic mice tent with the data presented above from cultured muscle cells (Figures 3 and 4) . compared to 2.5-fold in the controls ( Figure 7D ). 
